25Jun
Blog: SEC Amendments to Financial Disclosure Requirements Provide a Welcome Reprieve for Carve-Out Transactions
As previously reported in this Cooley PubCo post, on May 21, the SEC adopted final amendments to the financial disclosure requirements for the acquisition and disposition of businesses. One change relating to the use of abbreviated financial statements stands out as a welcome reform for public or pre-public biopharma and life sciences companies....
By:
Cooley LLP
Related
The United States District Court of Oregon (“Court”) addressed in an April 14th Opinion an action ...
Read More >
As employers are likely aware, cases of the 2019 Novel Coronavirus (also referred to as COVID-19, bu...
Read More >
Many readers will remember The Jetsons – a futuristic world in which sophisticated robots in both t...
Read More >
Employers paid out a record $68.2 million to those alleging sexual harassment violations through the...
Read More >
One of the hosts of this show, Ronnie Feldman is the author of an article entitled ‘Ethics and Comp...
Read More >
Our European Antitrust and Mergers & Acquisitions Groups examine changes in the way European competi...
Read More >